NanoString Launches $55M Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of the market Tuesday that it has launched a follow-on public offering of $55 million of common stock.

The Seattle-based firm, which went public last summer, announced the offering last week and has granted the underwriters a 30-day option to purchase up to an additional $8.25 million of its common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.